Perioperative chemotherapy for advanced gastric cancer - results from a tertiary-care hospital in Germany

Table 1 Patient characteristics before therapy

Characteristic	129 patients	%
Ages at diagnosis
Average	69.8 yr (SD: ± 11.4)
Median	71 yr (range: 38-91)
Ages at diagnose
< 75 yr	76	59% of 129
≥ 75 yr	53	41% of 129
≥ 80 yr	24	19% of 129
Gender
Male	93	72% of 129
Female	36	28% of 129
Tumour sites
Proximal	47	36% of 129
Distal	82	64% of 129
Proximal < 75 yr	34	72% of 47
Proximal ≥ 75 yr	13	28% of 47
Among whom proximal ≥ 80 yr	1	2% of 47
Distal < 75 yr	42	51% of 82
Distal ≥ 75 yr	40	49% of 82
Among whom distal ≥ 80 yr	23	28% of 82
Perioperative chemotherapy
Yes	45	35% of 129
No	84	65% of 129
Ages at perioperative chemotherapy
Median of all 45 patients	66 yr (range: 38-82)
Average of all 45 patients	65.7 yr (SD: ± 8.6)
< 75 yr	37	82% of 45
≥ 75 yr	8	18% of 45
Among whom ≥ 80 yr	1	1% of 45
Ages of patients without perioperative chemotherapy
Median of all 84 patients	75 yr (range: 44-91)
Average of all 84 patients	72 yr (SD: ± 11.9)
< 75 yr	39	46% of 84
≥ 75 yr	45	54% of 84
Among whom ≥ 80 yr	23	27% of 84

SD: Standard deviation.